Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daphne Day

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Genome Medicine|October 30, 2016
Approaches to modernize the combination drug development paradigmDaphne Day, Lillian L Siu
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 17, 2016
Immune-Related Adverse Events Associated with Immune Checkpoint InhibitorsDaphne Day, Aaron R Hansen
JACC. Cardiooncology|January 13, 2023
Immune Checkpoint Inhibitor Therapy in Oncology: Current Uses and Future Directions: <i>JACC: CardioOncology</i> State-of-the-Art ReviewSean Tan, Daphne Day, Stephen J Nicholls, et al.
Clinical Case Reports|March 26, 2021
Synchronous p16<sup>+</sup> nasopharyngeal and oropharyngeal squamous cell carcinoma: a case report and reviewMuhammad Ali, Hock Kua, Charles Giddings, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|April 10, 2025
A randomized controlled trial: Evaluating whether a cognitive behavioral internet-delivered intervention targeting emotion regulation improves health-related quality of life in cancer survivorsRebecca Wallace, Isabelle Smith, Daphne Day, et al.
Cancer Reports (Hoboken, N.J.)|July 10, 2021
Recruitment, outcomes, and toxicity trends in phase I oncology trials: Six-year experience in a large institutionSiddharth Menon, Amy Davies, Sophia Frentzas, et al.
Bone|February 7, 2026
Atypical femoral fracture with early PET/CT changes from denosumab for metastatic breast cancer and transition from denosumab to zoledronic acidChelsea Tan, Daphne Day, Michelle White, et al.
Behavioral Medicine (Washington, D.C.)|June 15, 2022
The Disease Influenced Vaccine Acceptance Scale-Six (DIVAS-6): Validation of a Measure to Assess Disease-Related COVID-19 Vaccine Attitudes and ConcernsLisa Grech, Bao Sheng Loe, Daphne Day, et al.
Current Oncology (Toronto, Ont.)|August 28, 2024
Equitable Access to Genomic Molecular Testing for Australian Cancer Patients: Insights from the Victorian Precision Oncology SummitGenevieve Dall, Karen Harris, Nonie Chan, et al.
JCO Global Oncology|June 26, 2023
Operational Challenges of an Asia-Pacific Academic Oncology Clinical TrialDaphne Day, Han Chong Toh, Raghib Ali, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Genome Medicine|October 30, 2016
Approaches to modernize the combination drug development paradigmDaphne Day, Lillian L Siu
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 17, 2016
Immune-Related Adverse Events Associated with Immune Checkpoint InhibitorsDaphne Day, Aaron R Hansen
JACC. Cardiooncology|January 13, 2023
Immune Checkpoint Inhibitor Therapy in Oncology: Current Uses and Future Directions: <i>JACC: CardioOncology</i> State-of-the-Art ReviewSean Tan, Daphne Day, Stephen J Nicholls, et al.
Clinical Case Reports|March 26, 2021
Synchronous p16<sup>+</sup> nasopharyngeal and oropharyngeal squamous cell carcinoma: a case report and reviewMuhammad Ali, Hock Kua, Charles Giddings, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|April 10, 2025
A randomized controlled trial: Evaluating whether a cognitive behavioral internet-delivered intervention targeting emotion regulation improves health-related quality of life in cancer survivorsRebecca Wallace, Isabelle Smith, Daphne Day, et al.
Cancer Reports (Hoboken, N.J.)|July 10, 2021
Recruitment, outcomes, and toxicity trends in phase I oncology trials: Six-year experience in a large institutionSiddharth Menon, Amy Davies, Sophia Frentzas, et al.
Bone|February 7, 2026
Atypical femoral fracture with early PET/CT changes from denosumab for metastatic breast cancer and transition from denosumab to zoledronic acidChelsea Tan, Daphne Day, Michelle White, et al.
Behavioral Medicine (Washington, D.C.)|June 15, 2022
The Disease Influenced Vaccine Acceptance Scale-Six (DIVAS-6): Validation of a Measure to Assess Disease-Related COVID-19 Vaccine Attitudes and ConcernsLisa Grech, Bao Sheng Loe, Daphne Day, et al.
Current Oncology (Toronto, Ont.)|August 28, 2024
Equitable Access to Genomic Molecular Testing for Australian Cancer Patients: Insights from the Victorian Precision Oncology SummitGenevieve Dall, Karen Harris, Nonie Chan, et al.
JCO Global Oncology|June 26, 2023
Operational Challenges of an Asia-Pacific Academic Oncology Clinical TrialDaphne Day, Han Chong Toh, Raghib Ali, et al.
Pageof 4